British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 ...

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and inflammation.

Britain's GSK and China's Jiangsu Hengrui Pharmaceuticals have agreed on a $500 million deal to develop up to a dozen new medicines, including a promising candidate for a chronic lung condition ...

Manufacturing GSK telegraphs 150 layoffs amid plan to transfer vaccine manufacturing from Massachusetts site By Fraiser Kansteiner Jul 22, 2025 8:53am GSK drug manufacturing vaccine manufacturing ...

Chris Ratcliffe/Bloomberg British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state.

As GSK pursues biotech tie-ups and reinvests in internal R&D capabilities, a "very limited number" of science roles will be eliminated.

Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug costs, and lost Medicaid rebates.

Senator Maggie Hassan is investigating GSK's controversial asthma inhaler switch, alleging the move put the medication out of reach for some patients.